NOEMR shows severe financial deterioration with current assets plummeting 67% while liabilities surge, despite an artificial net income boost likely from non-operating items.
The company appears to be in financial distress as evidenced by negative stockholders equity worsening to -$1.8M and the need for a $1.5M working capital facility from its sponsor. The massive decline in current assets combined with increased liabilities and worsening operating losses suggests potential liquidity challenges that could threaten the SPAC's ability to complete its business combination within the required timeframe.
NOEMR's financial position deteriorated significantly with current assets collapsing 67% to just $383K while current liabilities jumped 81% to $805K, creating a severe working capital deficit. Operating performance worsened substantially with operating losses increasing 163% to -$646K and operating cash flow declining 144% to -$745K. The 62,679% surge in net income to $1.7M appears artificial and likely stems from non-operating gains, masking the underlying operational deterioration and growing financial distress evidenced by the increasingly negative equity position.
Net income grew 62679.6% — bottom-line growth signals improving overall business health.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Operating cash flow fell 143.9% — earnings quality concerns; investigate working capital changes and non-cash items.
Current liabilities surged 80.7% — significant near-term obligations; verify ability to meet short-term debt.
Current assets declined 67.4% — monitor working capital adequacy and short-term liquidity.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Liabilities increased 14.3% — monitor debt-to-equity ratio and interest coverage.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →